Document is current
Any future updates will be listed below
-
Authors
Le Louet, Solenne https://orcid.org/0000-0002-8485-7129
Barkaoui, Mohamed-Aziz
Miron, Jean
Galambrun, Claire
Aladjidi, Nathalie
Chastagner, Pascal
Kebaili, Kamila
Armari-Alla, Corinne
Lambilliotte, Anne
Lejeune, Julien
Moshous, Despina
Della Valle, Valeria
Sileo, Chiara
Ducou Le Pointe, Hubert
Chateil, Jean-François
Renolleau, Sylvain
Piloquet, Jean-Eudes
Portefaix, Aurelie
Epaud, Ralph
Chiron, Raphaël
Bugnet, Emmanuelle
Lorillon, Gwenaël
Tazi, Abdelatif
Emile, Jean-François
Donadieu, Jean
Héritier, Sébastien
-
Funding
Funding for this research was provided by:
Agence Française de Sécurité Sanitaire de l'Environnement et du Travail
Recherche et Maladie Hématologiques de l'Enfant
Les 111 des Arts
Association la Petite Maison dans la Prairie
Association Histiocytose France
- License Information
-
More Information
Article History
Received: 6 April 2020
Accepted: 5 August 2020
First Online: 9 September 2020
Ethics approval and consent to participate
: All children were registered in French LCH registry. Patients in the registry had to fulfill LCH diagnostic criteria. Additionally their parents had to provide informed consent (Commission Nationale d’Informatique et des Libertés number in France: 909027) for a prospective follow-up. This procedure complied with the Declaration of Helsinki.
: N/A
: The French LCH registry was supported by a grant from Roche. J.D. received travel support and honoraria from X4 Pharma. J.-F.E. received honoraria from Bristol-Myers Squibb, MSD Oncology, HalioDx, Pierre Fabre, and Amgen. We declare no other conflict of interest.
